215 related articles for article (PubMed ID: 20842915)
1. [Oxalic acid--important uremic toxin].
Mydlík M; Derzsiová K
Vnitr Lek; 2010 Jul; 56(7):695-701. PubMed ID: 20842915
[TBL] [Abstract][Full Text] [Related]
2. Oxalic Acid as a uremic toxin.
Mydlík M; Derzsiová K
J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Vitamin B6 and oxalic acid in clinical nephrology.
Mydlík M; Derzsiová K
J Ren Nutr; 2010 Sep; 20(5 Suppl):S95-102. PubMed ID: 20797580
[TBL] [Abstract][Full Text] [Related]
5. [Urinary oxalic acid excretion in chronic kidney failure and after kidney transplantation].
Mydlík M; Derzsiová K; Pribylincová V; Reznícek J
Vnitr Lek; 1996 Dec; 42(12):813-7. PubMed ID: 9072879
[TBL] [Abstract][Full Text] [Related]
6. Influence of water and sodium diuresis and furosemide on urinary excretion of vitamin B(6), oxalic acid and vitamin C in chronic renal failure.
Mydlík M; Derzsiová K; Zemberová E
Miner Electrolyte Metab; 1999; 25(4-6):352-6. PubMed ID: 10681666
[TBL] [Abstract][Full Text] [Related]
7. Renal replacement therapy and secondary hyperoxalemia in chronic renal failure.
Mydlík M; Derzsiová K
Kidney Int Suppl; 2001 Feb; 78():S304-7. PubMed ID: 11169031
[TBL] [Abstract][Full Text] [Related]
8. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
10. [Secondary oxalosis in chronic renal insufficiency].
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142
[TBL] [Abstract][Full Text] [Related]
11. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Alcázar Arroyo R
Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
[TBL] [Abstract][Full Text] [Related]
12. [The effect of furosemide on urinary excretion of oxalic acid, vitamin C and vitamin B6 in chronic kidney failure].
Mydlík M; Derzsiová K; Zemberová E; Rajnic A
Vnitr Lek; 1998 Mar; 44(3):127-31. PubMed ID: 9820088
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
[TBL] [Abstract][Full Text] [Related]
14. [Oral administration of iron with vitamin C in haemodialyzed patients].
Derzsiová K; Mydlík M; Boldizsár J; Hríbiková M; Petrovicová J
Vnitr Lek; 2001 Apr; 47(4):210-4. PubMed ID: 15635885
[TBL] [Abstract][Full Text] [Related]
15. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction and oxidative stress in chronic renal failure.
Ghiadoni L; Cupisti A; Huang Y; Mattei P; Cardinal H; Favilla S; Rindi P; Barsotti G; Taddei S; Salvetti A
J Nephrol; 2004; 17(4):512-9. PubMed ID: 15372412
[TBL] [Abstract][Full Text] [Related]
17. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
18. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
[TBL] [Abstract][Full Text] [Related]
19. Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease.
Busch M; Göbert A; Franke S; Ott U; Gerth J; Müller A; Stein G; Bitsch R; Wolf G
Nephron Clin Pract; 2010; 114(1):c38-46. PubMed ID: 19816042
[TBL] [Abstract][Full Text] [Related]
20. LIGHT--a new member of the TNF superfamily in the plasma, dialysate and urine of uremic patients; the impact of residual diuresis and presence of viral hepatitis.
Pawlak K; Pawlak D; Mysliwiec M
Clin Biochem; 2007 Nov; 40(16-17):1240-4. PubMed ID: 17826757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
